Standout Papers

Lifileucel, an Autolog... 2017 2026 2020 2023 486
  1. Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors (2024)
    Adam J. Schoenfeld, Scott Gettinger et al. Cancer Discovery
  2. Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study (2017)
    Joshua Bauml, Tanguy Y. Seiwert et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Open-ST: High-resolution spatial transcriptomics in 3D
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
3 intermediate papers

Works of Ammar Sukari being referenced

458 First phase 2 results of autologous tumor-infiltrating lymphocyte (TIL; LN-145) monotherapy in patients with advanced, immune checkpoint inhibitor-treated, non-small cell lung cancer (NSCLC)
2021
A user’s guide to lorlatinib
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Ammar Sukari 1458 615 361 626 114 2.2k
Panagiota Economopoulou 1351 576 279 864 103 2.6k
Pol Specenier 1045 536 445 613 80 1.9k
Xiuyu Cai 974 632 129 422 96 2.0k
Nicole G. Chau 1224 439 468 621 79 2.2k
Conor Steuer 1404 1326 420 772 120 2.7k
Pantaleo Bufo 762 551 249 1125 106 2.8k
Christian Borel 1170 476 365 341 77 1.8k
Andreas Schalhorn 1785 795 456 608 89 2.9k
Caroline Even 1706 795 817 315 141 2.4k
Sacha I. Rothschild 1406 824 119 823 127 2.6k

All Works

Loading papers...

Rankless by CCL
2026